Home / News & View /Details

Event Preview | Symposium of Clinical Strategies for Precision Radiopharmaceuticals

Jiangsu (China) | 01 June 2025

Date: August 30, 2025


Location: Ma'anshan, China


Theme: Global Synergy for Integrated Radiopharmaceutical Development


Radiopharmaceuticals are rapidly emerging as a key focus in global healthcare innovation. However, clinical adoption still faces significant challenges. To accelerate progress, the Radiopharmaceutical Clinical Strategy Forum, held alongside RDC CHINA 2025, will convene leading voices from academia, industry, and investment to drive integrated solutions.


Highlights include:


20+ international experts sharing insights on clinical translation and innovation


10+ emerging companies presenting cutting-edge technologies


50+ top investors exploring opportunities in radiopharmaceuticals


Sessions focused on science, clinical strategy, and commercialization


Join us in Ma’anshan to shape the future of nuclear medicine — through collaboration, innovation, and global synergy.


Previous: Norroy Showcased Three Oral Presentations at SNMMI 2025, Unveiling Next-Generation Radiopharmaceuticals for Renal Cancer and Beyond Next: Norroy Bioscience Presents Promising Renal Cancer Imaging Data at 2025 ASCO Annual Meeting
Return to List

Contact the Media Relations Department

This is the media section, we welcome inquiries from the media